Beth Israel Deaconess Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Beth Israel Deaconess Medical Center sits in the top decile of US sponsors by registered trial count (#75 of 15,742 sponsors by registered trial count).
Beth Israel Deaconess Medical Center: 488 sponsored US clinical trials, 66 recruiting.
Beth Israel Deaconess Medical Center sponsors 488 registered US clinical trials on ClinicalTrials.gov, 66 of them currently recruiting, and 321 completed. 45 of these trials are in Phase 3-4 (later-stage) and 144 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 8 trials.
Top-decile sponsor footprint
Beth Israel Deaconess Medical Center ranks in the top decile of sponsors by registered trial count (#75 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
321 of 380 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
488 total, page 7 of 10
Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS
NCT01702987
Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa
NCT01670500
Ubiquinol (Reduced COQ10) for Patients With Sepsis
NCT01948063
Sleep Effectiveness and Insulin and Glucose Homeostasis
NCT01887691
Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss
NCT01780870
Tai Chi After Pulmonary Rehabilitation in Patients With COPD: A Randomized Trial
NCT01998724
Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)
NCT01678300
Enhancement of Brain Circuit of Inhibitory Control in Obese Patients Undergoing Gastric Banding
NCT01632280
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
NCT01561859
Quercetin PK/PD Study in Healthy Adults and Patients With Hypercoagulable States
NCT01722669
Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota
NCT01473368
Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism
NCT01653132
Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI
NCT01562678
Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy
NCT01522235
Seizure Activity in Alzheimer's Disease
NCT01554683
Therapeutic Efficacy of Transcranial Magnetic Stimulation in Schizophrenia
NCT01551979
Randomized Study of Stereotactic Body Radiotherapy vs. Conventional Radiation for Spine Metastasis
NCT01525745
Effect of Increased Free Fatty Acids on Leptin Function
NCT01520454
PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine
NCT01441765
Aerosol Inhalation Treatment for Dyspnea
NCT01440764
Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness
NCT01462279
Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
NCT01397734
Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist
NCT03070730
Kidney Donor Outcomes Cohort (KDOC) Study
NCT01427452
Repeated Challenge of Insufficient Sleep: Endothelial Effects
NCT01523535
Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota
NCT01414010
Repeating Patterns of Sleep Restriction and Recovery
NCT01523691
A Clinical Study to Limit Physiologic Intestinal FDG Uptake Uptake on PET-CT Scans
NCT01542541
Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast Cancer
NCT01468649
N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis
NCT01354132
Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease
NCT01349504
BEAM COPD: Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease (COPD)
NCT01551953
Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation
NCT01319110
Effects of a Combined Transcranial Magnetic Stimulation (TMS) and Cognitive Training in Alzheimer Patients
NCT01504958
Effect on Acetaminophen Metabolism by Liquid Formulations
NCT01246713
Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
NCT01299038
JC Virus Reactivation in Multiple Sclerosis
NCT02004444
Effectiveness of Open and Robotic Prostatectomy
NCT01325506
Dance Exercise as Novel Complementary Therapy for Parkinson's Disease
NCT01163344
The Optimal Dosage of Intrathecal Morphine for Peripartum Analgesia
NCT01146457
Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Therapy in Metastatic Renal Cell Carcinoma
NCT00953446
Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
NCT01206322
rTMS for Motor and Mood Symptoms of Parkinson's Disease
NCT01080794
Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
NCT01096602
Ketorolac Effects on Post-operative Pain and Bone Healing
NCT01133639
Study of Leptin for the Treatment of Hypothalamic Amenorrhea
NCT00130117
Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing Therapy for PD-related Voice/Speech Impairment
NCT01163331
Comparing Google With A Focused Diabetes Search Engine
NCT01080976
Improvement of Insulin Resistance After Bariatric Surgery
NCT03853590
Glycemic Index and Brain Function
NCT01064778
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 53 |
| Phase 2 | 91 |
| Phase 3 | 13 |
| Phase 4 | 32 |
Therapeutic Areas
What is open in the Beth Israel Deaconess Medical Center pipeline
66 recruiting of 488 indexed (14% open); 321 completed (66%).
Phase mix: 45 late (III/IV) vs 144 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Beth Israel Deaconess Medical Center: open-pipeline peers nationwide
Peers matched on 488 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Beth Israel Deaconess Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 488 trials (± recruiting share)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 490 trials · 10% recruiting
- Fred Hutchinson Cancer Center · 483 trials · 12% recruiting
- National Heart, Lung, and Blood Institute (NHLBI) · 501 trials · 12% recruiting
- H. Lee Moffitt Cancer Center and Research Institute · 502 trials · 16% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Wayne State University · 13% recruiting · 163 trials
- University of Michigan · 13% recruiting · 1,327 trials
- Albany Medical College · 13% recruiting · 52 trials
Related
What to do with this Beth Israel Deaconess Medical Center page
488 registered trials is a research-attention snapshot, not an endorsement of Beth Israel Deaconess Medical Center or any single study.
- 66 of Beth Israel Deaconess Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Beth Israel Deaconess Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Beth Israel Deaconess Medical Center pipeline card: 488 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.